labetalol has been researched along with Kidney Diseases in 8 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This double-blind, controlled, crossover study compared the effects on blood pressure control, glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) of labetalol, methyldopa and placebo in patients with chronic renal disease and hypertension." | 9.07 | The short term effects of oral labetalol in patients with chronic renal disease and hypertension. ( Catto, GR; Edward, N; Gemmell, HG; Innes, A; Smith, FW, 1992) |
| " In a double-blind cross-over study the antihypertensive action and side-effects of labetalol and propranolol were compared in 18 previously untreated outpatients with hypertension, WHO stage I--III." | 9.05 | Labetalol in the treatment of hypertension in patients with normal and impaired renal function. ( Berg, KJ; Nilsen, OG; Walstad, RA; Wessel-Aas, T, 1982) |
| "This double-blind, controlled, crossover study compared the effects on blood pressure control, glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) of labetalol, methyldopa and placebo in patients with chronic renal disease and hypertension." | 5.07 | The short term effects of oral labetalol in patients with chronic renal disease and hypertension. ( Catto, GR; Edward, N; Gemmell, HG; Innes, A; Smith, FW, 1992) |
| " In a double-blind cross-over study the antihypertensive action and side-effects of labetalol and propranolol were compared in 18 previously untreated outpatients with hypertension, WHO stage I--III." | 5.05 | Labetalol in the treatment of hypertension in patients with normal and impaired renal function. ( Berg, KJ; Nilsen, OG; Walstad, RA; Wessel-Aas, T, 1982) |
| "Labetalol is a unique antihypertensive agent which is a competitive peripheral antagonist at both alpha- and beta-adrenoceptor sites." | 2.37 | Current status of labetalol, the first alpha- and beta-blocking agent. ( Kanto, JH, 1985) |
| "1 Labetalol was given to 41 hypertensive patients in a divided dosage of 150--2,400 mg daily for periods ranging from 1--64 months." | 1.26 | Monotherapy with labetalol for hypertensive patients with normal and impaired renal function. ( Hussein, MM; Joekes, AM; Thompson, FD, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mok, CC | 1 |
| Kwan, TH | 1 |
| Chow, L | 1 |
| Aruny, JE | 1 |
| Perazella, MA | 1 |
| Breen, EG | 1 |
| Lombard, M | 1 |
| Watson, A | 1 |
| Keogh, JA | 1 |
| Walstad, RA | 1 |
| Berg, KJ | 1 |
| Wessel-Aas, T | 1 |
| Nilsen, OG | 1 |
| Thompson, FD | 1 |
| Joekes, AM | 1 |
| Hussein, MM | 1 |
| Bailey, RR | 1 |
| Innes, A | 1 |
| Gemmell, HG | 1 |
| Smith, FW | 1 |
| Edward, N | 1 |
| Catto, GR | 1 |
| Kanto, JH | 1 |
1 review available for labetalol and Kidney Diseases
| Article | Year |
|---|---|
Current status of labetalol, the first alpha- and beta-blocking agent.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia; Biot | 1985 |
2 trials available for labetalol and Kidney Diseases
| Article | Year |
|---|---|
Labetalol in the treatment of hypertension in patients with normal and impaired renal function.
Topics: Adult; Aged; Double-Blind Method; Ethanolamines; Female; Half-Life; Humans; Hypertension; Kidney Dis | 1982 |
The short term effects of oral labetalol in patients with chronic renal disease and hypertension.
Topics: Administration, Oral; Adult; Blood Pressure; Chronic Disease; Double-Blind Method; Female; Glomerula | 1992 |
5 other studies available for labetalol and Kidney Diseases
| Article | Year |
|---|---|
Scleroderma renal crisis sine scleroderma during pregnancy.
Topics: Adult; Antihypertensive Agents; Arteries; Captopril; Drug Therapy, Combination; Female; Humans; Hype | 2003 |
An odd case of hypertension.
Topics: Adrenal Cortex Hormones; Adult; Antihypertensive Agents; Cyclophosphamide; Female; Humans; Hypertens | 2006 |
Labetolol in patients with hypertension and varying degrees of renal impairment.
Topics: Adult; Aged; Ethanolamines; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Disease | 1984 |
Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.
Topics: Blood Pressure; Creatinine; Dose-Response Relationship, Drug; Ethanolamines; Humans; Hypertension; K | 1979 |
Labetalol in the treatment of patients with hypertension and renal function impairment.
Topics: Adolescent; Adult; Aged; Blood Pressure; Child; Emergencies; Ethanolamines; Female; Glomerular Filtr | 1979 |